Advertisement

Update 1989 pp 154-164 | Cite as

Judicious Use of Antibiotics in Critically Ill Patients

  • D. Pittet
  • P. M. Suter
Conference paper
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 8)

Abstract

Infection remains a significant problem for the management of patients in the intensive care unit (ICU). In the United States, more than 26% of nosocomial infections, as well as 20 to 40% of bacteremia and 25% of pneumonia acquired within the hospital occur in ICU patients [1, 2]. Such infections are in part a result of advances in medical technology: invasive diagnostic and therapeutic procedures, alteration of host immune responses, overuse of antimicrobial agents. Appropriate use of antibiotics could reduce the morbidity and mortality in the ICU, as well as the high cost of hospital acquired infections.

Keywords

Intensive Care Unit Nosocomial Infection Intensive Care Unit Patient Selective Decontamination Surgical Prophylaxis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Massanari RM, Hierholzer WJ Jr (1986) The intensive care unit. In: Bennett JV, Brockman PS (eds) Hospital infections, 2nd edn. Little, Brown & Co, New YorkGoogle Scholar
  2. 2.
    Wenzel RP, Thompson RL, Landry SM, et al (1983) Hospital-acquired infections in intensive care unit patients: An overview with emphasis on epidemics. Infect Control 4:371–375PubMedGoogle Scholar
  3. 3.
    McGowan JE Jr (1983) Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 5:1033–1048PubMedCrossRefGoogle Scholar
  4. 4.
    Johanson WG, Pierce AK, Sanford JP (1969) Changing pharyngeal bacterial flora of hospitalized patients. N Engl J Med 281:1137–1140PubMedCrossRefGoogle Scholar
  5. 5.
    Ristuccia PA, Cunha BA (1987) Microbiologic aspects of infection control. In: Wenzel RP (ed) Prevention and control of nosocomial infections. Williams & Wilkins, Baltimore London Los Angeles Sydney (chapter 14), pp 205–232Google Scholar
  6. 6.
    Kerver AJ, Rommes JH, Mevissen-Verhage EA, et al (1987) Colonization and infection in surgical intensive care patients. A prospective study. Intensive Care Med 13:347–351PubMedCrossRefGoogle Scholar
  7. 7.
    Hamory RA (1987) Nosocomial bloodstream and intravascular device-related infections. In: Wenzel RP (ed) Prevention and control of nosocomial infections. Williams & Wilkins, Baltimore London Los Angeles Sydney (chapter 19), pp 283–319Google Scholar
  8. 8.
    Horn R, Wong B, Kiehn TE, Armstrong D (1985) Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 7:646–655PubMedCrossRefGoogle Scholar
  9. 9.
    Kusne S, Dummer JS, Singh N, et al (1988) Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine 67:132–143PubMedCrossRefGoogle Scholar
  10. 10.
    Powderly WG, Kobayashi GS, Herzig GP, Medoff G (1988) Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 84:826–832PubMedCrossRefGoogle Scholar
  11. 11.
    Neu HC (1984) Changing mechanisms of bacterial resistance. Am J Med 77:11–23PubMedCrossRefGoogle Scholar
  12. 12.
    Waldvogel FA (1985) Staphylococcus aureus (including toxic shock syndrome). In: Man-dell GL, Douglas RG Jr, Bennett JE (eds) Principles and practices of infectious diseases, 2nd edn. Wiley, New York, pp 1097–1117Google Scholar
  13. 13.
    Neu HC (1984) Infections in intensive care patients: Use of new β-lactams. Bull NY Acad Med 60:732–735Google Scholar
  14. 14.
    Cohen SN (1976) Transposable genetic elements and plasmid evolution. Nature 263:731–734PubMedCrossRefGoogle Scholar
  15. 15.
    Sanders CC, Moellering RC Jr, Martin RR, et al (1982) Resistance to cefamendole: A collaborative study of emerging clinical problems. J Infect Dis 145:118–125PubMedCrossRefGoogle Scholar
  16. 16.
    Sanders CC, Sanders WE Jr (1983) Emergence of resistance during therapy with the newer β-lactam antibiotics: Role of inducible β-lactamases and implications for the future. Rev Infect Dis 5:639–648PubMedCrossRefGoogle Scholar
  17. 17.
    Sanders CC (1984) Failure to detect resistance in antimicrobial susceptibility tests: A “very major” error of increasing concern. Antimicrob Newslett 1:27–31CrossRefGoogle Scholar
  18. 18.
    Pancoast SJ (1988) Aminoglycoside antibiotics in clinical use. Update on Antibiotics II. Med Clin North Am 72:581–612PubMedGoogle Scholar
  19. 19.
    Calderwood SA, Wennersten C, Moellering RC Jr, Kunz LJ (1977) Resistance to six aminoglycoside aminocyclitol antibiotics among enterococci: Prevalence, evolution, and relationship to synergism with penicillin. Antimicrob Agents Chemother 12:401–405PubMedGoogle Scholar
  20. 20.
    Moody M, De Jongh CA, Schimpff SC, Tillman GL (1982) Long-term amikacin use: Effects on amino-glycoside susceptibility patterns of gram-negative bacilli. JAMA 248:1199–1202PubMedCrossRefGoogle Scholar
  21. 21.
    Barber M (1961) Methicillin-resistant staphylococci. J Clin Pathol 14:385–393PubMedCrossRefGoogle Scholar
  22. 22.
    Peacock JE, Moorman DR, Wenzel RP, et al (1981) Methicillin-resistant Staphylococcus aureus: Microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain. J Infect Dis 144:575–582PubMedCrossRefGoogle Scholar
  23. 23.
    Schaberg DR, Weinstein RA, Stamm WE (1976) Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli epidemiology and control. J Infect Dis 133:363–366PubMedCrossRefGoogle Scholar
  24. 24.
    Albert RK, Condie F (1981) Hand-washing patterns in medical intensive units. N Engl J Med 304:1465–1466PubMedCrossRefGoogle Scholar
  25. 25.
    Thompson RL, Carbezudo I, Wenzel RP (1982) Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 97:309–317PubMedGoogle Scholar
  26. 26.
    Goldmann DA, Durbin WA Jr, Freeman J (1981) Nosocomial infections in a neonatal intensive care unit. J Infect Dis 144:449–457PubMedCrossRefGoogle Scholar
  27. 27.
    Haley RW, Bregman DA (1982) The role of understaffing and overcrowding in recurrent outbreaks of staphylococcal infection in a neonatal special care unit. J Infect Dis 145:875–885PubMedCrossRefGoogle Scholar
  28. 28.
    Weinstein RA, Kabins SA (1981) Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med 70:449–454PubMedGoogle Scholar
  29. 29.
    Donowitz LG, Wenzel RP, Hoyt JW (1982) High risk of hospital-acquired infection in the ICU patient. Crit Care Med 10:355–357PubMedCrossRefGoogle Scholar
  30. 30.
    Daschner FD, Frey P, Wolff G, Baumann PC, Suter PM (1982) Nosocomial infections in intensive care wards: A multicenter prospective study. Intensive Care Med 8:5–9PubMedCrossRefGoogle Scholar
  31. 31.
    Sanders CC, Sanders WE (1985) Microbial resistance to newer generation β-lactam antibiotics: Clinical and laboratory implications. J Infect Dis 151:399–406PubMedCrossRefGoogle Scholar
  32. 32.
    Kunin CM (1985) Problems in antibiotics usage. In: Mandell GL, Douglas RG Jr, Bennett JR (eds) Principles and practice of infectious diseases, 2nd edn. Wiley, New York, pp 301–307Google Scholar
  33. 33.
    Price DJE, Sleigh JD (1970) Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet 2:1213–1215PubMedCrossRefGoogle Scholar
  34. 34.
    Kaiser AB (1986) Antimicrobial prophylaxis in surgery. N Engl J Med 315:1129–1138PubMedCrossRefGoogle Scholar
  35. 35.
    Atherton ST, White DJ (1978) Stomach as a source of bacteria colonising respiratory tract during artificial ventilation. Lancet 2:968–969PubMedCrossRefGoogle Scholar
  36. 36.
    McA Ledingham I, Alcock SR, Eastaway AT, et al (1988) Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet 1:785–790CrossRefGoogle Scholar
  37. 37.
    Du Moulin GC, Paterson DG, Hedley-White J, Lisbon A (1982) Aspiration of gastric bacteria in antacid-treated patients: A frequent cause of postoperative colonisation in the airway. Lancet 1:242–245PubMedGoogle Scholar
  38. 38.
    Stoutenbeek CP, Van Saene HFK, Miranda DR, Zandstra DF (1984) The effect of selective decontamination of the digestive tract on colonisation and infection rates in multiple trauma patients. Intensive Care Med 10:185–192PubMedCrossRefGoogle Scholar
  39. 39.
    Stoutenbeek CP, Van Saene HKF, Zandstra DF (1987) The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care. J Antimicrob Chemother 19:513–520PubMedCrossRefGoogle Scholar
  40. 40.
    Fuhs DW, Mann HJ, Kubajak CA, Cerra FB (1988) Intrapatient variation of aminoglycoside pharmacokinetics in critically ill surgery patients. Clin Pharm 7:207–213PubMedGoogle Scholar
  41. 41.
    Garaud JJ, Regnier B, Inglebert F, Faurisson F, Bauchet J, Vachon F (1984) Vancomycin pharmacokinetics in critically ill patients. J Antimicrob Chemother 14: Suppl D: 53–57PubMedGoogle Scholar
  42. 42.
    Wolfson JS, Swartz MN (1985) Serum bactericidal activity as a monitor of antibiotic therapy. N Engl J Med 312:968–975PubMedCrossRefGoogle Scholar
  43. 43.
    Lipman B, Neu HC (1988) Imipenem: A new carbapenem antibiotic. Med Clin North Am 72:567–579PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • D. Pittet
  • P. M. Suter

There are no affiliations available

Personalised recommendations